₨25,000.00Original price was: ₨25,000.00.₨19,999.00Current price is: ₨19,999.00.
Tofaxen (Tofacitinib) 5mg – 60 Tablets | Imported from India
Tofaxen 5mg is a prescription medication containing Tofacitinib, a Janus kinase (JAK) inhibitor. It is used in the treatment of autoimmune and inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By blocking specific enzymes in the JAK pathway, Tofaxen helps reduce inflammation, pain, and joint damage.
Composition
Each film-coated tablet contains: Tofacitinib 5 mg
Indications
Tofaxen is prescribed for adults with:
Moderate to severe rheumatoid arthritis (RA)
Active psoriatic arthritis (PsA)
Moderate to severe ulcerative colitis (UC) in patients who did not respond to other treatments
Dosage & Administration
Typical adult dose: 5 mg twice daily (as prescribed by a physician)
Can be taken with or without food
Tablets should be swallowed whole with water
Mechanism of Action
Tofacitinib is a JAK inhibitor that blocks Janus kinase enzymes responsible for immune system overactivity
Helps reduce inflammation, pain, stiffness, and swelling
Prevents progression of joint damage in rheumatoid and psoriatic arthritis
Tofaxen (Tofacitinib) 5mg Tablets – Uses, Side Effects & Precautions
Tofaxen 5mg Tablets contain Tofacitinib, a Janus kinase (JAK) inhibitor prescribed for the treatment of multiple autoimmune and inflammatory conditions. By targeting the JAK pathway, it helps reduce inflammation, relieve pain, and improve overall quality of life in patients with chronic joint and intestinal disorders.
Medical Uses of Tofaxen 5mg
Tofacitinib (Tofaxen) is commonly prescribed for:
Rheumatoid Arthritis (RA): For moderate to severe cases when other treatments, such as methotrexate, are not effective.
Psoriatic Arthritis (PsA): Helps control joint pain, swelling, and stiffness in patients with psoriatic arthritis.
Ankylosing Spondylitis (AS): Reduces inflammation and symptoms associated with this chronic spinal condition.
Ulcerative Colitis (UC): Effective in treating moderately to severely active cases of ulcerative colitis.
Polyarticular Juvenile Idiopathic Arthritis (pJIA): Approved for children with joint inflammation and stiffness.
Common Side Effects
Some patients may experience mild side effects such as:
Reviews
There are no reviews yet.